Should I Buy LNZA? LNZA 2026 Analysis

Should You Buy Lanzatech Global Inc (LNZA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.540

1 Day change

7.33%

52 Week Range

107.000

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient trader: the dominant trend is still bearish (negative/expanding MACD, bearish moving-average stack).
Although RSI is extremely oversold and price is sitting at key support (around 10.55 vs S1 ~10.575), there is no Intellectia buy signal confirming a timing edge.
With weak recent financial momentum and an analyst explicitly flagging near-term funding/dilution risk, the risk/reward favors waiting for confirmation (reclaiming resistance/pivot) rather than buying immediately.

Technical Analysis

Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), signaling a sustained downtrend.
Momentum: MACD histogram is negative (-0.246) and expanding lower, suggesting downside momentum is still strengthening.
RSI: RSI_6 at ~10.83 indicates extreme oversold conditions; a short-term bounce is possible, but oversold alone is not a buy trigger in a strong downtrend.
Levels: Price 10.55 is essentially on S1 (10.575). A clean break below could open room toward S2 (~~9.535). Upside recovery would need to reclaim the pivot (~~12.26) to improve the technical picture.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment (Open Interest): Put/Call OI ratio at 0.21 is call-heavy, generally a bullish tilt.
Activity/Conviction (Volume): Option volume is effectively zero (Put/Call volume ratio 0.0), so current sentiment signals have low reliability.
Volatility: 30D IV ~69.31 vs HV ~65.3 (slight premium). IV percentile ~22 and IV rank ~4.99 suggest IV is relatively low vs its own recent history, but the lack of volume limits trade-read confidence.

Technical Summary

Sell

Buy

Positive Catalysts

- Technical mean-reversion setup: extremely oversold RSI near a defined support level can produce sharp dead-cat/relief rallies.
- Call-heavy open interest (low put/call OI ratio) implies more upside positioning than downside hedging (though conviction is unclear given zero volume).
- Pattern-based projection suggests a potentially favorable 1-month skew (+12.54% over next month), despite weak near-term odds.

Neutral/Negative Catalysts

- Strong bearish trend remains intact: negative and worsening MACD plus bearish MA stack.
- Near-term downside risk: price is sitting on support (S1). A break could accelerate toward ~9.54 (S2).
- Fundamental/financing overhang: analyst cites near-term funding challenges and potential dilutive future funding.
- No news catalysts in the last week to change the narrative or spark a re-rating.
- Short-horizon statistical outlook is unfavorable: model indicates -2.6% expected move over the next week.

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: 9,279,000, down -6.68% YoY (top-line contraction).
Profitability: Net income 2,861,000, down -104.98% YoY; EPS 1.07, down -103.68% YoY (large deterioration vs prior-year comp).
Margin: Gross margin 14.42, up +186.11% YoY (a bright spot), but not enough to offset the broader growth/earnings decline indicated here.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent action (2025-11-19): Roth Capital lowered price target to $14 from $20 and maintained a Neutral rating after Q3 revenue missed expectations.
Wall Street pro view (pros): Still sees upside to the lowered target vs current price (implies recovery potential if execution improves).
Wall Street con view (cons): Explicit caution on near-term funding needs, inability to hit financial targets, and a capital structure that may require very dilutive funding—these are material overhangs.
Ownership/trading sentiment checks: Hedge funds Neutral (no significant quarterly trend); insiders Neutral (no significant monthly trend).
Influential/political trading: No recent congress trading data available; no politician/influential-figure activity provided.

1 Analyst Rating

Wall Street analysts forecast LNZA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LNZA is 14 USD with a low forecast of 14 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

Current: 9.820

Low

Averages

High

Current: 9.820

Low

Averages

High

Roth Capital

Neutral

downgrade

$20 -> $14

AI Analysis

2025-11-19

Reason

Roth Capital

Price Target

$20 -> $14

AI Analysis

2025-11-19

downgrade

Neutral

Reason

Roth Capital lowered the firm's price target on LanzaTech to $14 from $20 and keeps a Neutral rating on the shares after its Q3 results, with revenue coming in light of estimates. The firm remains cautious on the stock due to the company's near-term funding challenges, its inability to execute on financial targets, and its capital structure, which contemplates "very dilutive future funding", the analyst tells investors in a research note.

Roth Capital

Buy -> Neutral

downgrade

$0.20

2025-05-19

Reason

Roth Capital

Price Target

$0.20

2025-05-19

downgrade

Buy -> Neutral

Reason

Roth Capital downgraded LanzaTech to Neutral from Buy with a 20c price target.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LNZA

Unlock Now

LNZA Should I Buy

LNZA Should I Buy

Should You Buy Lanzatech Global Inc (LNZA) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch